Global (AMER, EMEA, BRICS and APAC) Nuclear Medicine Market Size, Status and Forecast 2019-2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Nuclear Medicine Market

 

Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide. The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years. In 2018, the global Nuclear Medicine market size was 4934.3 million US$ and it is expected to reach 8143.8 million US$ by the end of 2025, with a CAGR of 7.4% during 2019-2025. This report focuses on the global Nuclear Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nuclear Medicine development in United States, Europe and China. 

Market Segmentation, Outlook & Regional Insights: Nuclear Medicine Market

Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:

Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other

Segmentation by Application: Breakdown of data from year 2014 to 2019 and forecast until 2025:


Diagnostic
Therapeutic
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Key Players, Recent Developments & Sector Viewpoints: Nuclear Medicine Market

GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng

Key Insights Covered: Exhaustive Nuclear Medicine Market
1.  Market size (sales, revenue and growth rate) of Nuclear Medicine industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Nuclear Medicine industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Nuclear Medicine industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Nuclear Medicine industry.

Research Methodology: Nuclear Medicine Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.